-
Stay on: Theravance Biopharma (NASDAQ:TBPH), ConocoPhillips (NYSE:COP), Invesco Mortgage Capital Inc. (NYSE:IVR), Weyco Group Inc. (NASDAQ:WEYS), Raptor Pharmaceuticals Corp. (NASDAQ:RPTP)
On February 24, Theravance Biopharma Inc (NASDAQ:TBPH) announced enrollment of the first patient in the Company’s Phase 3 registrational study of telavancin in patients with Staphylococcus aureus bacteremia. The trial is designed to support a regulatory filing for telavancin as a treatment for Staphylococcus aureus bacteremia. Bacteremia is the presence of bacteria in the bloodstream…
-
Sizzling Stocks: LKQ Corp. (NASDAQ:LKQ), Twitter Inc (NYSE:TWTR), Edgewater Technology Inc. (NASDAQ:EDGW), Theravance Biopharma (NASDAQ:TBPH), Peapack-Gladstone Financial Corp. (NASDAQ:PGC)
LKQ Corp. (NASDAQ:LKQ) has named John Quinn as its executive vice president, chief financial officer, managing director and CEO of its European operations. Dominick Zarcone succeeds Quinn as executive vice president and CFO. On Thursday shares of LKQ Corp. (NASDAQ:LKQ) closed at $24.78. Company’s sales growth for last 5 years was 21.50% and EPS growth…
-
What’s Hot: U.S. Silica Holdings (NYSE:SLCA), Theravance Biopharma (NASDAQ:TBPH), German American Bancorp (NASDAQ:GABC), American DG Energy (NYSEMKT:ADGE), Revett Mining (NYSEMKT:RVM)
U.S. Silica Holdings, Inc. (NYSE: SLCA) Board of Directors has declared a quarterly cash dividend of $0.125 per common share. The dividend is payable on April 3, 2015 for all shareholders of record as of the close of business on March 16, 2015.On Tuesday shares of U.S. Silica Holdings, Inc. (NYSE:SLCA) closed at $31.90. Company’s…
-
What’s Hot: Cognex Corporation (NASDAQ:CGNX), AK Steel Holding Corporation (NYSE:AKS), Pfizer Inc. (NYSE:PFE), Millennial Media Inc. (NYSE:MM), Theravance Biopharma (NASDAQ:TBPH)
Cognex Corporation (NASDAQ:CGNX) announced that the company set new annual records for revenue, net income and earnings per share in 2014. Revenue increased 22% over Q4 2013 and decreased 31% from Q3 2014. Growth year-on-year came from the factory automation market and surface inspection, which set a new quarterly revenue record. On a sequential basis,…
-
Investors Are Eying: TherapeuticsMD (NYSEMKT:TXMD), Midstates Petroleum Company (NYSE:MPO), Willis Group Holdings PLC (NYSE:WSH), Cal-Maine Foods (NASDAQ:CALM), Theravance Biopharma (NASDAQ:TBPH)
TherapeuticsMD, Inc. (NYSE MKT:TXMD) announced the launch of an underwritten public offering of shares of its common stock. TherapeuticsMD also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock to cover overallotments, if any. All of the shares in the offering are to…
-
Hot Watch List: Cleveland BioLabs (NASDAQ:CBLI), Opko Health (NYSE:OPK), Theravance Biopharma (NASDAQ:TBPH), Equity Residential (NYSE:EQR), The Brink’s Company (NYSE:BCO)
On Jan 27, Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced that at a special meeting of stockholders held on January 27, 2015, stockholders authorized the Company’s Board of Directors to effect a reverse stock split of the Company’s common stock at a ratio in the range of 1:2 to 1:20. On Tuesday shares of Cleveland BioLabs, Inc.…
-
Active Movers: Microsoft Corporation (NASDAQ:MSFT), Mexco Energy Corporation (NYSEMKT:MXC), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), CYS Investments (NYSE:CYS), Theravance Biopharma (NASDAQ:TBPH)
Microsoft Corporation (NASDAQ:MSFT) announced that Michael Gough has joined the company as corporate vice president of design for the Applications and Services Group (ASG). On Monday shares of Microsoft Corporation (NASDAQ:MSFT) closed at $41.28. Company’s sales growth for last 5 years was 8.20% and EPS growth for next 5 years is recorded as 8.37%. Mexco…
-
Biotech Bulls: Curis (NASDAQ:CRIS), CorMedix (NYSEMKT:CRMD), Theravance Biopharma (NASDAQ:TBPH), GenVec (NASDAQ:GNVC), Genocea Biosciences (NASDAQ:GNCA)
On 21st January Curis, Inc. (NASDAQ:CRIS), and Aurigene Discovery Technologies Limited, announced that they have entered into an exclusive collaboration agreement focused on immuno-oncology and selected precision oncology targets. On Monday shares of Curis, Inc. (NASDAQ:CRIS) closed at $1.95. Company’s sales growth for last 5 years was 12.30%. CorMedix Inc. (NYSE MKT: CRMD), on 29…
-
Stocks Gaining Momentum: Theravance Biopharma (NASDAQ:TBPH), Walter Investment Management Corp. (NYSE:WAC), PBF Energy Inc. (NYSE:PBF), Netflix (NASDAQ:NFLX), TetraLogic Pharmaceuticals (NASDAQ:TLOG)
Theravance Biopharma, Inc. (NASDAQ:TBPH) and Mylan Inc. (MYL) announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases. On Monday shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) closed at…
-
Traders Should Watch: Imation Corp. (NYSE:IMN), Intel Corporation (NASDAQ:INTC), Authentidate Holding Corp. (NASDAQ:ADAT), Theravance Biopharma (NASDAQ:TBPH), Level 3 Communications (NYSE:LVLT)
On Jan 09, Imation Corp. (NYSE:IMN) said it is scheduled to release the Company’s fourth quarter 2014 financial results on Tuesday, February 10, 2015 at 6:00 a.m. Central time. A teleconference for the financial community and a live webcast are scheduled that day from 9:00 to 10:00 a.m. Central time. On Friday shares of Imation…